News & Events

• March 26, 2020
  

  ePRO Consortium Announces Open Access Article

  In collaboration with the DIA Study Endpoints Community, C-Path’s ePRO Consortium is pleased to announce the open access article “Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials” is available online in the April 1, 2020 issue of Contemporary Clinical Trials. This article provides recommendations for the structure and content of an evidence dossier aimed at supporting a clinical trial endpoint derived from mobile sensor data as fit-for-purpose in regulatory decision making.

  Link to article: https://www.contemporaryclinicaltrials.com/article/S1551-7144(20)30040-9/fulltext

• December 2, 2019
  

  Workshop Summary, Advancing the Development and Implementation of Analysis Data Standards, Now Available

  C-Path is proud to announce the availability of the workshop summary, Advancing the Development and Implementation of Analysis Data Standards: Key Challenges and Opportunities. The workshop, in collaboration with the Duke-Margolis Center for Health Policy and the Food and Drug Administration (FDA), was planned with the support of C-Path data standard expertise, and included a......
• October 29, 2019
  

  U.S. Senator Martha McSally Visits C-Path

  U.S. Senator Martha McSally (Arizona) visited Tucson-based Critical Path Institute (C-Path) Friday, October 25, to learn more about its mission to accelerate drug development. C-Path, founded in 2005, aims to catalyze the development of new approaches that advance medical innovation and regulatory science through collaboration and public and private partnerships. “C-Path is a unique leader......
• September 30, 2019
  

  The Critical Path for Parkinson’s Consortium (CPP) welcomes PMD Alliance as newest member

  The Critical Path for Parkinson’s Consortium (CPP) is thrilled to welcome the PMD Alliance (Parkinson & Movement Disorder Alliance) as our newest member. The PMD Alliance is an independent, national nonprofit organization that provides opportunities for people impacted by Parkinson’s and other movement disorders to learn, live life more fully, and connect with others. Their......
• August 12, 2019
  

  C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting Scientist

  C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting Scientist. Currently a Professor of Neurology at the University of Arizona College of Medicine – Tucson, Dr. Restifo is a neurogeneticist with broad interests in translational medicine. She will be using her expertise to help CPP......